RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 66.65
-1.70 (-2.49%)
Oct 14, 2026, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 55.93 billion as of October 14, 2026. It is the 2,762nd most valuable company in the world and the 146th biggest in Hong Kong. Its market cap has increased by 1.96% in one year.
Market Cap
55.93B
Enterprise Value
50.35B
Revenue
9.24B
Global Rank
Country Rank
#146 Hong Kong
PE Ratio
5.56
ChartMarket Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 55.93B, an increase of 67.50%. That is a compound annual growth rate of 9.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 55.93B | 23.73% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | 106.27B |
| Akeso | 100.50B |
| Genscript Biotech | 96.69B |
| Sino Biopharmaceutical | 96.35B |
| Biocytogen Pharmaceuticals (Beijing) | 52.95B |
| 3SBio | 37.56B |
| Shanghai Junshi Biosciences | 34.94B |
| InSilico Medicine Cayman TopCo | 28.22B |